Dr Jessamy Tiffen retweeted
Thrilled to share new work led by @JieYang437 in the lab published today in @Nature. We find that Aspirin prevents metastasis by releasing T cells from immune suppression by platelet TXA2. @Cambridge_Uni @CRUKCamCentre rdcu.be/eci1U
Deeply concerned for my US collaborators……
In an unprecedented move, research-grant reviews have been suspended indefinitely at the world’s largest public funder of biomedical research
go.nature.com/4gclXG0
Dr Jessamy Tiffen retweeted
1. What are the benefits and risks of GLP1?
Our new study in @naturemedicine comprehensively maps all the benefits and risks of GLP-1 receptor agonists (GLP-1) (Ozempic, Wegovy, Mounjaro, Zepbound).
By @Biostayan, Taeyoung Choi and me
🧵
nature.com/articles/s41591-0…
Dr Jessamy Tiffen retweeted
Cancer statistics in 2025 🇺🇸- new report 🚨
Cancer is becoming a new disease.
We're seeing a fundamental shift in who gets cancer, moving from a predominantly male, elderly disease to one that increasingly affects women and younger people.
Key highlights 🧵
Super fun BBQ and swim at my house for past and present lab members and their families. Stephen and Alice are about to graduate with their MDs. Great science is so much more about the people than experiments. @DrHYTseng @CentenaryInst
SEX! Now that I have your attention, check out our review on these fascinating yet under appreciated chromosomes with roles in cancer survival outcomes. onlinelibrary.wiley.com/doi/…
Looks like it’s back to the ARC grants. #AcademicTwitter
Super grateful to the AMRF for supporting Laura’s project on an epigenetic switch for undifferentiated melanoma.
Congratulations to Dr @JessTiffen & master’s student Laura Nicholls, who have been awarded a $10,000 research grant from @MelanomaAU . The grant will support Laura’s study into a resilient type of melanoma that often evades current treatments. More: centenary.org.au/news/resear…
Dr Jessamy Tiffen retweeted
The 10 biggest cancer papers of the last 10 years (in my opinion)
1. Blocking PD1 activates the immune response against cancer - especially if the cancer has more mutations
nejm.org/doi/pdf/10.1056/NEJ…
Dr Jessamy Tiffen retweeted
You're invited to our FREE interactive online event Skin Deep: understanding melanoma. For more information and to register go to: centenary.org.au/event/skin-…
#centenaryinstitute #melanoma #medicalresearch #medicalwebinar
Dr Jessamy Tiffen retweeted
I am looking for a post doc to join my new lab @Sydney_Uni! This is a great opportunity for an ECR to work with my team using cutting edge imaging approaches 🔬 to dive into bone metastatic breast cancer … and enjoy the Sydney life ☀️ 🏖️🤗 usyd.wd3.myworkdayjobs.com/e…
Jennifer Doudna at the Sydney Opera House with my favourite neuroscientist. @DrEleanorD
More great work from my team on epigenetic BET inhibitors.
Here we show they combine well with antiCTLA-4 immune checkpoint inhibition (ICI) to combat melanoma with innate resistance to antiPD-1/L1 (frontline) ICI in a mouse model.
@DrHYTseng @emran_geb
onlinelibrary.wiley.com/doi/…
This is remarkable. Cancer in the complete absence of a single genetic mutation. Another win for team epigentics! nature.com/articles/s41586-0…
Like Catherine, more under-50s are being diagnosed with cancer smh.com.au/national/like-cat…
Estimating cancers attributable to physical inactivity in Australia - Journal of Science and Medicine in Sport jsams.org/article/S1440-2440…
FDA approves first tumour-infiltrating lymphocyte (TIL) therapy, bolstering hopes for cell therapies in solid cancers nature.com/articles/d41573-0…
When you meet with cardiology folks on Valentines Day, you get heart shaped treats ❤️@Vrushalikc @CSHeartResearch @rdbagnall
Dr Jessamy Tiffen retweeted
The @JessTiffen lab is focused on understanding how epigenetic dysregulation drives melanoma development & how this differs between the sexes. More: centenary.org.au/research/la… #worldcancerday #closethecaregap #centenaryinstitute #WorldCancerDay2024 #melanoma #Cancer #CancerResearch
Dr Jessamy Tiffen retweeted
It's a mistake to think that the only wins in the #PhD worth celebrating are the big flashy events - submission, acceptance, awards.
Here are 30 other wins in the PhD you might think are "no big deal" 🧵
#phdlife #phdchat #academicchatter #academictwitter #phdtips






















